Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media

Pediatric Infectious Disease Journal

Volumn 19, Issue 12 SUPPL., 2000, Pages

  Block, S L ^a   Kratzer, J ^a   Nemeth, M A ^a   Tack, K J ^a  

^a NONE   (United States)

Author keywords

Acute otitis media; Cefdinir; Cefprozil; Children

Indexed keywords

ANTIBIOTIC AGENT; CEFDINIR; CEFPROZIL; CEPHALOSPORIN DERIVATIVE;

ACUTE DISEASE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ACUTE DISEASE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA; TREATMENT OUTCOME;

EID: 0034541658     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200012001-00003     Document Type: Article

References (24)

1. Otitis media
2. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group
3. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis
4. Duration of therapy for acute otitis media
5. Treatment failures in otitis media: What can we learn?
6. Management of acute otitis media in the 1990's: The decade of resistant pneumococcus
7. Cefprozil treatment of persistent and recurrent acute otitis media
8. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns, and antimicrobial management
9. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin) two new oxazolidinones (U-100592) and U-100766), and other oral and parenteral agents against penicillin-susceptible and-resistant pneumococci
10. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children
11. Prevalence of antimicrobial resistant pathogens in middle ear fluid: Multinational study of 917 children with acute otitis media
12. Five-day twice daily cefdinir therapy for acute otitis media: Microbiologic and clinical efficacy
13. Host factors and early therapeutic response in acute otitis media
14. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective cohort study
15. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams
16. Efficacy of amoxicillin/clavulanate for acute otitis media: Relation to Streptococcus pneumoniae susceptibility
17. Cefdinir versus amoxicillin/clavulanate in the treatment of suppurative acute otitis media in children
18. Otitis media: Back to basics
19. Five vs. ten days of antibiotic therapy for acute otitis media in young children
20. Effectiveness of five days of therapy with cefuroxime axetil suspension for the treatment of acute otitis media
21. The promise of immunoprophylaxis for prevention of acute otitis media
22. Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children
23. Variation in acceptance of common oral antibiotic suspensions
24. Selection of pediatric antibiotic suspensions: Taste and cost factors